Inventor
SCHLEGL ROBERT
AT29 patents
⚠️ This page may combine multiple inventors who share the name “SCHLEGL ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VALNEVA AUSTRIA GMBH
16 patentsUS11219681B2Jan 11, 2022
Zika virus vaccine
VALNEVA AUSTRIA GMBH9 citations93
US10744194B2Aug 18, 2020
Zika virus purification
VALNEVA AUSTRIA GMBH11 citations93
US11331382B2May 17, 2022
Zika virus purification
VALNEVA AUSTRIA GMBH4 citations83
US10668146B2Jun 2, 2020
Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines
VALNEVA AUSTRIA GMBH3 citations83
US10639365B2May 5, 2020
Zika virus vaccine
VALNEVA AUSTRIA GMBH6 citations83
US11466058B2Oct 11, 2022
Mutant fragments of OspA and methods and uses relating thereto
VALNEVA AUSTRIA GMBH4 citations82
US10544194B2Jan 28, 2020
Mutant fragments of OspA and methods and uses relating thereto
VALNEVA AUSTRIA GMBH8 citations82
US12102673B2Oct 1, 2024
Zika virus vaccine
VALNEVA AUSTRIA GMBH0 citations72
US11110170B2Sep 7, 2021
Aluminum compounds for use in therapeutics and vaccines
VALNEVA AUSTRIA GMBH1 citations72
US9913898B2Mar 13, 2018
Aluminum compounds for use in therapeutics and vaccines
VALNEVA AUSTRIA GMBH2 citations71
US11684669B2Jun 27, 2023
CpG-adjuvanted SARS-CoV-2 virus vaccine
VALNEVA AUSTRIA GMBH6 citations70
US9884115B2Feb 6, 2018
Aluminum compounds for use in therapeutics and vaccines
VALNEVA AUSTRIA GMBH2 citations69
US12005111B2Jun 11, 2024
Zika virus vaccine
VALNEVA AUSTRIA GMBH0 citations62
US11951163B2Apr 9, 2024
Zika virus vaccine
VALNEVA AUSTRIA GMBH0 citations62
US12527863B2Jan 20, 2026
Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines
VALNEVA AUSTRIA GMBH0 citations61
US9248180B2Feb 2, 2016
IC31 nanoparticles
VALNEVA AUSTRIA GMBH0 citations48
VALNEVA SE
8 patentsUS10537630B2Jan 21, 2020
Virus purification
VALNEVA SE15 citations93
US10660950B2May 26, 2020
Virus purification
VALNEVA SE8 citations92
US10662412B2May 26, 2020
Aseptic purification process for viruses
VALNEVA SE2 citations73
US12214033B2Feb 4, 2025
Virus purification
VALNEVA SE0 citations72
US12011477B2Jun 18, 2024
Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3
VALNEVA SE1 citations71
US11484587B2Nov 1, 2022
Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3
VALNEVA SE3 citations64
US11629339B2Apr 18, 2023
Aseptic purification process for viruses
VALNEVA SE0 citations62
US12564625B2Mar 3, 2026
Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Δ5nsP3
VALNEVA SE0 citations61